本页面由Tiger Trade Technology Pte. Ltd.提供服务

Silence Therapeutics Plc

8.87
-0.7800-8.08%
盘后:8.870.00000.00%16:10 EDT
成交量:145.00万
成交额:1,307.53万
市值:5.51亿
市盈率:-6.99
高:9.57
开:9.53
低:8.71
收:9.65
52周最高:17.58
52周最低:4.19
股本:6,215.41万
流通股本:5,017.17万
量比:1.34
换手率:2.89%
股息:- -
股息率:- -
每股收益(TTM):-1.2693
每股收益(LYR):-1.8761
净资产收益率:-90.41%
总资产收益率:-29.65%
市净率:14.33
市盈率(LYR):-4.73

数据加载中...

2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/20

SEC问询函

CORRESP [Cover] - Correspondence
2021/04/29

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/11

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/11

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/03/09

招股说明书

F-1 - Registration statement for certain foreign private issuers
2021/02/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/09/02

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/26

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/08/20

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/20

招股说明书

F-1 - Registration statement for certain foreign private issuers
2017/12/08

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2017/12/01

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2017/01/13

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership